Closing Strong: Travere Therapeutics Inc (TVTX) Ends at 14.01, Down -6.85 from Last Close

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $15.04 in the prior trading day, Travere Therapeutics Inc (NASDAQ: TVTX) closed at $14.01, down -6.85%. In other words, the price has decreased by -$6.85 from its previous closing price. On the day, 2.93 million shares were traded. TVTX stock price reached its highest trading level at $14.9 during the session, while it also had its lowest trading level at $13.972.

Ratios:

Our goal is to gain a better understanding of TVTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 26.62 whereas as Long-Term Debt/Eq ratio is at 26.27.

Citigroup Upgraded its Neutral to Buy on December 05, 2023, whereas the target price for the stock was revised from $7 to $10.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’24 when Calvin Sandra bought 15,000 shares for $14.80 per share.

Inrig Jula sold 684 shares of TVTX for $8,878 on Sep 10 ’24. The CHIEF MEDICAL OFFICER now owns 61,949 shares after completing the transaction at $12.98 per share. On Sep 09 ’24, another insider, ROTE WILLIAM E., who serves as the SENIOR VICE PRESIDENT, R&D of the company, sold 4,387 shares for $11.52 each. As a result, the insider received 50,538 and left with 84,455 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1071646016 and an Enterprise Value of 1149475712. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.03 while its Price-to-Book (P/B) ratio in mrq is 70.72. Its current Enterprise Value per Revenue stands at 6.471 whereas that against EBITDA is -4.179.

Stock Price History:

Over the past 52 weeks, TVTX has reached a high of $15.36, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 32.43%, while the 200-Day Moving Average is calculated to be 64.65%.

Shares Statistics:

The stock has traded on average 1.44M shares per day over the past 3-months and 2404050 shares per day over the last 10 days, according to various share statistics. A total of 75.37M shares are outstanding, with a floating share count of 75.34M. Insiders hold about 1.52% of the company’s shares, while institutions hold 117.55% stake in the company. Shares short for TVTX as of 1726185600 were 8657111 with a Short Ratio of 6.01, compared to 1723680000 on 9295562. Therefore, it implies a Short% of Shares Outstanding of 8657111 and a Short% of Float of 12.73.

Most Popular